AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES

Clinical trials for AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES explained in plain language.

Never miss a new study

Get alerted when new AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES trials appear

Sign up with your email to follow new studies for AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

First safety check: new drug tested in people with kidney problems

Knowledge-focused Completed

This early-stage study aimed to understand how a new drug called remibrutinib is processed by the body in people with severe kidney impairment. It involved 16 participants—half with poor kidney function and half healthy—to measure drug levels in their blood and urine. The goal wa…

Matched conditions: AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused

Last updated Apr 01, 2026 14:42 UTC

AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES

Get alerted when new AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES trials appear

First safety check: new drug tested in people with kidney problems